Oral NSAI Versus Acetaminophen or Placebo as a Discharge Treatment of Non Complicated Renal Colics
ConditionRenal Colic
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Monastir
About this trial
Treatment with NSAI in renal colics has not been well investigated and there is no clear recommendations regarding this subject.
The aim of this study is to determine if an oral NSAI treatment is beneficial in patients discharged for the emergency department after the first line treatment of a renal colic investigating the reccurence of pain, the reconsultation rates and the admissions.
Eligibility criteria
Qualifiers
Over 18 years old
Consenting to participate in the study
Patients treated in the ED for RC
No contraindications of NSAI or paracetamol treatment
Disqualifiers
Contraindication of NSAI treatment
Patients non reachable by telephone call
Patients that did not receive or use the treatment
Trial design
Treatments tested in this trial
- Piroxicam
- Acetaminophen
- Placebo
Treatment groups
500 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov